Global analysis of differentially expressed genes in androgen-independent prostate cancer

被引：30
|
作者：
Wei, Q.
Li, M.
Fu, X.
Tang, R.
Na, Y.
Jiang, M.
Li, Y. [1 ]
机构：
[1] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China
[2] Peking Univ, First Hosp, Dept Urol, Beijing 100871, Peoples R China
来源：
PROSTATE CANCER AND PROSTATIC DISEASES | 2007年 / 10卷 / 02期
基金：
中国国家自然科学基金;
关键词：
androgen independent; expression profile; hormone; angiogenesis; microarray;
D O I：
10.1038/sj.pcan.4500933
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Progression to androgen independent ( AI) is the main cause of death in prostate cancer, and the mechanism is still unclear. By reviewing the expression profiles of 26 prostate cancer samples in a holistic view, we found a group of genes differentially expressed in AI compared with androgen-dependent groups ( P- value < 0.01, t- test). Focusing on apoptosis, proliferation, hormone and angiogenesis, we found a group of genes such as thioredoxin domain containing 5, tumor necrosis factor receptor superfamily, member 10a, ribosomal protein S19 and Janus kinase 2 upregulated in AI prostate cancer, could play important roles in the transition from AD to AI and could be biomarkers of prognosis.
引用
收藏
页码：167 / 174
页数：8
相关论文
共 50 条
  • [21] Effects and mechanisms of action of SARI on androgen-independent prostate cancer (DU145) cells
    Chen, Qian
    Gu, Yonghong
    Zhang, Shengwang
    Deng, Hao
    TUMOR BIOLOGY, 2016, 37 (12) : 16141 - 16149
  • [22] Catalytically active peptidylglycine α-amidating monooxygenase in the media of androgen-independent prostate cancer cell lines
    Trendel, Jill A.
    Ellis, Nicole
    Sarver, Jeffrey G.
    Klis, Wieslaw A.
    Dhananjeyan, Mugunthu
    Bykowski, Crystal A.
    Reese, Michael D.
    Erhardt, Paul W.
    JOURNAL OF BIOMOLECULAR SCREENING, 2008, 13 (08) : 804 - 809
  • [23] An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines
    Paliouras, Miltiadis
    Diamandis, Eleftherios P.
    BIOLOGICAL CHEMISTRY, 2008, 389 (06) : 773 - 780
  • [24] FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer
    Chua, CW
    Lee, DTW
    Ling, MT
    Zhou, C
    Man, K
    Ho, J
    Chan, FL
    Wang, XH
    Wong, YC
    INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (06) : 1039 - 1048
  • [25] Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model
    Morgenbesser, Sharon D.
    McLaren, Rajashree P.
    Richards, Brenda
    Zhang, Mindy
    Akmaev, Viatcheslav R.
    Winter, Scott F.
    Mineva, Nora D.
    Kaplan-Lefko, Paula J.
    Foster, Barbara A.
    Cook, Brian P.
    Dufault, Michael R.
    Cao, Xiahong
    Wang, Clarence J.
    Teicher, Beverly A.
    Klinger, Katherine W.
    Greenberg, Norman M.
    Madden, Stephen L.
    PROSTATE, 2007, 67 (01): : 83 - 106
  • [26] Histological changes caused by meclofenamic acid in androgen-independent prostate cancer tumors: evaluation in a mouse model
    Delgado-Enciso, Ivan
    Soriano-Hernandez, Alejandro D.
    Rodriguez-Hernandez, Alejandrina
    Galvan-Salazar, Hector R.
    Montes-Galindo, Daniel A.
    Martinez-Martinez, Rafael
    Valdez-Velazquez, Laura L.
    Gonzalez-Alvarez, Rafael
    Espinoza-Gomez, Francisco
    Newton-Sanchez, Oscar A.
    Lara-Esqueda, Agustin
    Guzman-Esquivel, Jose
    INTERNATIONAL BRAZ J UROL, 2015, 41 (05): : 1002 - 1007
  • [27] Increased frequency of venous thromboembolism with the combination of docetaxel and thalidomide in patients with metastatic androgen-independent prostate cancer
    Horne, MK
    Figg, WD
    Arlen, P
    Gulley, J
    Parker, C
    Lakhani, N
    Parnes, H
    Dahut, WL
    PHARMACOTHERAPY, 2003, 23 (03): : 315 - 318
  • [28] Progression to androgen-independent LNCap human prostate tumors: Cellular and molecular alterations
    Zhou, JR
    Yu, LY
    Zerbini, LF
    Libermann, TA
    Blackburn, GL
    INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (06) : 800 - 806
  • [29] Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models
    Tesan, Tajana
    Gustavsson, Helene
    Welen, Karin
    Damber, Jan-Erik
    BJU INTERNATIONAL, 2008, 102 (08) : 1034 - 1039
  • [30] Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: Scientific rationale and study design
    Beekman, Kathleen W.
    Colevas, A. Dimitrios
    Cooney, Kathleen
    DiPaola, Robert
    Dunn, Rodney L.
    Gross, Mitchell
    Keller, Evan T.
    Pienta, Kenneth J.
    Ryan, Charles J.
    Smith, David
    Hussain, Maha
    CLINICAL GENITOURINARY CANCER, 2006, 4 (04) : 299 - 302
12345